Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 09, 2024 08:00 ET | Source: Creyon Bio, Inc.

Creyon Bio Appoints Venture Capitalists Serge Messerlian and Shaquille Vayda to Board of Directors

SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Creyon Bio, Inc. ("Creyon"), a clinical-stage leader in AI/machine learning-enabled engineering of...
September 04, 2024 08:00 ET | Source: Creyon Bio, Inc.

Creyon Bio Granted Second U.S. Patent for AI/Machine Learning-Enabled Oligonucleotide-Based Medicine Engineering Platform

Patent protects Creyon™ Platform’s proprietary method for rapid engineering and optimization of therapeutic oligonucleotides with AI/ML, accelerating development timelines Recent publication details...
May 07, 2024 08:00 ET | Source: Creyon Bio, Inc.

Creyon Bio to Present Clinical Data on Rapid AI-Enabled Engineering of Oligonucleotide-Based Medicines at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting

AI-informed drug design enabled approval to dose within one year of project initiation Data highlight use of AI to engineer investigative allele selective antisense oligonucleotide treatment for baby...
May 01, 2024 08:00 ET | Source: Creyon Bio, Inc.

Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases

SAN DIEGO and RESEARCH TRIANGLE PARK, N.C. and SEATTLE, May 01, 2024 (GLOBE NEWSWIRE) -- Creyon Bio, Inc. ("Creyon"), a drug development company that engineers Oligonucleotide-Based Medicines (OBMs)...